The rise of biologics is having a dramatic impact on how physicians treat many serious and chronic illnesses. While these drugs have great promise, biologics are complex and, as a result, are very expensive to manufacture and subject to technical pitfalls. Pharmaceutical companies looking to add biologics to their pipelines must come up with innovative ways to approach drug development and cut the high costs associated with it.
One way to do this is to simplify the processes to produce and purify recombinant proteins. Simpler processes result in reduced production costs and a faster time to market. In this white paper, we review how the Corynex® Protein Expression System uses an extensive toolbox to improve the levels of protein secretion and overall success rate.

DOWNLOAD TO LEARN MORE >>>>